Immunopharmacological action of sinomenine, an alkaloid isolated from Sinomenium acutum, and its mechanism of action in treating rheumatoid arthritis

Yaoxue Xuebao

Volumn 40, Issue 2, 2005, Pages 127-131

  Liu, Ji Hong ^a   Li, Wei Dong ^a   Teng, Hui Ling ^a   Lin, Zhi Bin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Apoptosis; Immunopharmacological effect; Rheumatoid arthritis; Sinomenine; Synovial cell

Indexed keywords

ALKALOID DERIVATIVE; CONCANAVALIN A; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; MONOCLONAL ANTIBODY CD3; SINOMENINE;

ADJUVANT ARTHRITIS; ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SUBPOPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE FUNCTION TEST; IMMUNOPHARMACOLOGY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MEDICINAL PLANT; MOUSE; NONHUMAN; RAT; RHEUMATOID ARTHRITIS; SINOMENIUM ACUTUM; SPLEEN LYMPHOCYTE; T LYMPHOCYTE; UPREGULATION;

ANIMALS; APOPTOSIS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CD4-CD8 RATIO; CELL PROLIFERATION; HUMANS; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MORPHINANS; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; SINOMENIUM; SPLEEN; SYNOVIAL MEMBRANE;

EID: 15944419560     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Li SY, Wang J, Gao P, et al. Effect of sinomenine on immunological function in mice [J]. Chin Tradit Herb Drugs, 1992,23(2):81-83.
2. Peng HM, Ding XY, Liu XS, et al. Immunological inhibitory effect of sinomenine [J]. Acta Pharmacol Sin, 1988,9(4):377-380.
3. Liu L, Buchner E, Beitze D, et al. Amelioration of rat experimental arthritis by treatment with the alkaloid sinomenine [J]. Int J Immunopharmacol, 1996, 18 (10):529-543.
4. Liu Q, Zhou LL, Li S. General development of sinomenine in chemistry, pharmacology and clinics [J]. Chin Tradit Herb Drugs, 1997, 28(4):247-249.
5. Zhang JT. Mordern Experiment Methods in Pharmacology [M]. Beijing: Peking Union Medical College and Beijing Medical University Press, 1998. 644-700.
6. Wang B, Chen MZ, Xu SY. Isolation and culture method of synovial cell from rat [J]. Chin Pharmacol Bull, 1994,10(1):73-75.
7. Cai Q, Han XH, Meng JM. Progress in pathology, physiology and biological clinic of rheumatoid arthritis [J]. Chin J Rheumatol, 2000,4 (3):183-185.
8. Vyse TJ, Todd JA. Genetic analyses of autoimmune disease [J]. Cell, 1996,85(3):311-318.
9. Pascual M, Mataran L, Jones G, et al. HLA haplotypes and susceptibility to rheumatoid arthritis more than class II genes [J]. Scand J Rheumatol, 2002,31(5):275-278.
10. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis [J]. N Engl J Med, 1978,298 (16):869-871.
11. van Zeben D, Hazes JM, Zwinderman AH, et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis [J]. Arthritis Rheum, 1991,34(7):822-830.
12. Gregersen PK, Sliver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis [J]. Arthritis Rheum, 1987,30(11):1205-1213.
13. Tak PP, Hintzen RQ, Teunissen JJ, et al. Expression of the activation antigen CD27 in rheumatoid arthritis [J]. Clin Immunol Immunopathol, 1996,80(2):129-138.
14. Berg L, Lampa J, Rogberg S. Increased peripheral T-cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNF-α receptors [J]. Ann Rheum Dis, 2001,60(2):133-139.
15. Weyand CM, Goronzy JJ, Takemura S. Interactions between T cells and B cells in rheumatoid arthritis [J]. Arthritis Res, 2000,2:457-463.
16. Breedveld FC, Verweij CL. T cells in rheumatoid arthritis [J]. Br J Rheumatol, 1997,36(6):617-619.
17. Goronzy JJ, Weyand CM. Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis [J]. Trends Immunol, 2001,22(5):251-255.
18. Lee DM, Weinblatt ME. Rheumatoid arthritis [J]. Lancet, 2001,358(9285):903-911.
19. Kyburz D, Corr M, Brinson DC, et al. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen [J]. J Immunol, 1999,163 (6):3116-3122.
20. Waring P, Mullbacher A. Cell death induced by the Fas/Fas ligand pathway and its role in pathology [J]. Immunol Cell Biol, 1999,77(4):312-317.
21. Lu Y. Progress in research of mechanism in rheumatoid arthritis [J]. Foreign Med Sci (Sect Immunol), 2001,24(5):256-258.
22. Hoa TT, Hasunuma T, Aono H, et al. Novel mechanism of selective apoptosis in synovial T cells of patients with rheumatoid arthritis [J]. J Rheumatol, 1996,23(8): 1332-1337.
23. - T cells from rheumatoid arthritis patients [J]. J Immunol, 1998,161(2):1018-1025.
24. Cope AP. Exploring the pathogenesis of rheumatoid arthritis in transgenic and mutant mice [J]. Curr Dir Autoimmun, 2001,3:64-93.
25. Cope AP. Exploring the reciprocal relationship between immunity and inflammation in chronic inflammatory arthritis [J]. Rheumatology, 2003,42(6):716-731.